Can­cer clin­ics could soon use cannabis drug

The Courier & Advertiser (Fife Edition) - - NEWS - SALLY WARDLE

A cannabis drug may help to ex­tend the lives of pan­cre­atic can­cer pa­tients un­der­go­ing chemo­ther­apy, new re­search sug­gests.

Sci­en­tists found mice with the dis­ease sur­vived al­most three times longer if they were treated with cannabi­noid Cannabid­iol (CBD) along­side chemo­ther­apy.

Lead re­searcher Pro­fes­sor Marco Falasca, from Queen Mary Univer­sity of Lon­don, said it was “a re­mark­able re­sult” and added: “Cannabid­iol is al­ready ap­proved for use in clin­ics, which means we can quickly go on to test this in hu­man clin­i­cal tri­als.

“If we can re­pro­duce these ef­fects in hu­mans, cannabid­iol could be in use in can­cer clin­ics al­most im­me­di­ately, com­pared to hav­ing to wait for au­thor­i­ties to ap­prove a new drug.”

The study ex­am­ined the im­pact of CBD on mice with pan­cre­atic can­cer re­ceiv­ing com­mon chemo­ther­apy drug Gem­c­itabine.

Mice treated with this com­bi­na­tion of drugs had a me­dian sur­vival of 56 days, com­pared to 20 days for those left un­treated, while mice re­ceiv­ing chemo­ther­apy alone lived for a me­dian 23.5 days.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.